Mayo Clinic Talks COVID-19 Miniseries Episode 26: Mayo Clinic Q&A - Atypical Kawasaki Disease, Recombination Events, and Antiviral Therapy Updates

Mayo Clinic Talks

Mayo Clinic Talks Podcast #161

COVID-19 Miniseries Episode 26: Mayo Clinic Q&A - Atypical Kawasaki Disease, Recombination Events, and Anti-Viral Therapy Updates

Registration required for CME credit

 

Listen on Apple Podcast  Listen on Google Play Music  Listen on Spotify

You can also listen through your favorite podcast platform:
Apple Podcasts | Google Play Music | Stitcher | Spotify


COVID-19 information evolves daily.  The views and perspectives shared in these resources are presented based on information available at the time of recording.
Recorded May, 2020

For the most up to date information visit:
CDC - Information for Healthcare Professionals about Coronavirus (COVID-19)
World Health Organization's Country & Technical Guidance - Coronavirus disease (COVID-19)
AskMayoExpert COVID-19 Navigator
COVID-19 Online Education, Resources and Updates

 

Guest: Gregory A. Poland, M.D.
@drgregpoland		Host: Halena M. Gazelka, M.D.
@hmgazelkamd


On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group, discusses how SARS-CoV-2 is mutating, atypical Kawasaki disease emerging in pediatric patients, updates in antiviral therapies and how scientists and researchers are rapidly gaining new knowledge about the virus and the disease that it causes.

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

 

Target Audience

This course is intended for primary care providers: physicians, nurse practitioners, and physician assistants

Learning Objectives

Upon completion of the Mayo Clinic Talks Podcast course, learners should be able to:

  • Describe the current treatment recommendations for patients with hyperlipidemia.
  • List the various categories of hypertension.
  • Describe the current pharmacologic treatment available for patients with osteoporosis.

Participation in this Mayo Clinic online course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.

Course summary
Available credit: 
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
Course opens: 
05/12/2020
Course expires: 
12/29/2022
Cost:
$10.00
Part of: 
Mayo Clinic Talks Podcast: COVID-19 Miniseries

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):

AMA

Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.

Available Credit

  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance

Price

Cost:
$10.00
Please login or register to take this course.

Thank you for joining us!  

Everything you need to complete this course is listed in the Course Progress column on this page's left-hand side.  This handy checklist has all of the course components needing completion.  Do them in any order, but completion of all is required for credit.
 

For cancellation details, contact cme@mayo.edu